MSCI China USA Biotech 65/35 Index

The MSCI China USA Biotech 65/35 Index aims to represent the performance of securities from MSCI Hong Kong Listed Southbound IMI Index and MSCI USA IMI Index with exposure to the GICS® Biotechnology Industry.
Index code
766405
Index type
Equity
Benchmark administrator
--
Div Yld (%)
0.74
P/E
54.01
P/E Fwd
36.49
P/BV
6.23
Number of constituents
35
Index Market Cap
$1.38 T
Largest constituent Market Cap
$211.80 B
Smallest constituent Market Cap
$3.13 B
Average constituent Market Cap
$39.46 B
Median constituent Market Cap
$15.56 B
Does this benchmark pursue ESG objectives?
N/A*
Data as of April 30, 2026 
* For ESG objective information, please see this page

Want to learn more about MSCI indexes?
Get in touch.